FDA gives six-months' grace for SUDs (single-use-devices) reprocessors
This article was originally published in Clinica
Executive Summary
The US FDA has told hospitals and third-party reprocessors that it has no intention of penalising them for being unable to comply with the agency's new regulatory scheme for reprocessed single-use devices (SUDs).